» Authors » Pradeep Haldar

Pradeep Haldar

Explore the profile of Pradeep Haldar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 350
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhat N, Vodicka E, Clifford A, Ananth K, Bavdekar A, Roy A, et al.
Vaccine . 2024 Nov; 44():126551. PMID: 39615343
Rotavirus is a leading cause of severe diarrheal disease in infants and young children worldwide. Vaccination offers the best protection against this disease, and two rotavirus vaccines were developed in...
2.
Borhade P, LeBoa C, Jayaprasad N, Date K, Haldar P, Harvey P, et al.
Am J Trop Med Hyg . 2024 Sep; 111(5):1060-1065. PMID: 39348826
In 2018, the Navi Mumbai Municipal Corporation implemented phase 1 of a public sector typhoid conjugate vaccine campaign in Navi Mumbai, India, targeting all children aged 9 months to 14...
3.
Terstappen J, Hak S, Bhan A, Bogaert D, Bont L, Buchholz U, et al.
Lancet Infect Dis . 2024 Sep; 24(12):e747-e761. PMID: 39326422
Respiratory syncytial virus (RSV) is the second most common pathogen causing infant mortality. Additionally, RSV is a major cause of morbidity and mortality in older adults (age ≥60 years) similar...
4.
Majumder J, Ray A, Haldar P, Roy A, Roy D, Chandra Mandal N, et al.
Vaccine X . 2024 Aug; 19:100532. PMID: 39157685
Background: To reduce burden of pneumonia, India has introduced Pneumococcal Conjugate vaccine (PCV) in routine immunization programme. The state of West Bengal, India introduced PCV in 2021. Uptake of new...
5.
Date K, LeBoa C, Hoffman S, Haldar P, Harvey P, An Q, et al.
Am J Trop Med Hyg . 2024 Aug; 111(4):848-852. PMID: 39137766
Typbar-TCV®, a typhoid conjugate vaccine (TCV), was prequalified by the World Health Organization in 2017. We evaluated its effectiveness in a mass vaccination program targeting children 9 months to 14...
6.
Mohanty L, John T, Pawar S, Venkat Ramanan P, Agarkhedkar S, Haldar P
Vaccines (Basel) . 2024 Apr; 12(4). PMID: 38675806
Background: In 2016, the Global Polio Eradication Initiative (GPEI) recommended the cessation of using type 2 oral poliovirus vaccine (OPV) and OPV, with countries having to switch from the trivalent...
7.
Kumar S, Mvundura M, Ray A, Haldar P, Lennon P, Muller N, et al.
Vaccine X . 2023 Sep; 15:100385. PMID: 37736536
This study evaluated the performance, acceptability, costs, and systems fit of three new cold chain devices in India: a second-generation ice-lined refrigerator (ILR), a solar direct drive (SDD) refrigerator, and...
8.
Da Silva K, Date K, Hirani N, LeBoa C, Jayaprasad N, Borhade P, et al.
mBio . 2023 Jul; 14(4):e0117923. PMID: 37504577
We performed whole-genome sequencing of 174 Typhi and 54 Paratyphi A isolates collected through prospective surveillance in the context of a phased typhoid conjugate vaccine introduction in Navi Mumbai, India....
9.
Koshal S, Ray A, Hora R, Kaur A, Quadri S, Mehra R, et al.
Vaccine X . 2023 Jun; 14:100328. PMID: 37346081
India had decided to roll out PCV in India in 2015, but successful implementation of any new vaccine introduction mandates an enormous effort. PCV was scaled up during the COVID-19...
10.
Mohanty M, Mohammad A, Verma H, Kumar A, Madkaikar M, Desai M, et al.
Bull World Health Organ . 2023 May; 101(5):346-354. PMID: 37131936
Individuals with primary immunodeficiencies who are infected with vaccine-derived polioviruses may continue to shed poliovirus for months and go undetected by surveillance programmes of acute flaccid paralysis. These patients therefore...